Real-time enrollment status for this gastric adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:32 AM UTC
| NCT Number | NCT07673887 |
| Recruiting Status | Recruiting |
| Condition | Gastric Adenocarcinoma |
| Phase | PHASE3 |
| Target Enrollment | 570 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | September 11, 2026 (Sep 11, 2026) |
As of October 15, 2026: Clinical trial NCT07673887 is currently recruiting participants. This phase3 study for gastric adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07673887 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07673887 was last updated Sep 11, 2026 (September 11, 2026). HelloStudys verifies this status automatically.